Cited by 354Vestibular and auditory disordersHearing, Cochlea, Tinnitus, GeneticsHearing Loss and Rehabilitation

Steroids for idiopathic sudden sensorineural hearing loss

Open access
Wei, Benjamin PC, Stathopoulos, Dimitra, O'Leary, Stephen·2013·Cochrane Database of Systematic Reviews

Abstract

Background This is an update of a Cochrane review first published in The Cochrane Library in Issue 1, 2006 and previously updated in 2009.Idiopathic sudden sensorineural hearing loss (ISSHL) is a clinical diagnosis characterised by a sudden deafness of cochlear or retrocochlear origin in the absence of a clear precipitating cause. Steroids are commonly prescribed to treat this condition. There is no consensus on their effectiveness. Objectives To determine whether steroids in the treatment of ISSHL a) improve hearing (primary) and b) reduce tinnitus (secondary).To determine the incidence of significant side effects from the medication. Search methods We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 22 April 2013. Selection criteria We identified all randomised controlled trials (with or without blinding) in which steroids were evaluated in comparison with either no treatment or a placebo. We considered trials including the use of steroids in combination with another treatment if the comparison control group also received the same other treatment. The two authors reviewed the full-text articles of all the retrieved trials of possible relevance and applied the inclusion criteria independently. Data collection and…

Integrity signals

Registry

Crossref · 10.1002/14651858.cd003998.pub3

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Systemic steroids, intratympanic or otherwise, are the mainstay of treatment for SSNHL.

    “Systemic steroids, intratympanic or otherwise, are the mainstay of treatment although their mechanism of action has not yet been clarified. 4”

Cited by

Sorted by citations

Authors
Wei, B. P., Stathopoulos, D., & O'Leary, S.
Affiliations
  • The University of Melbourne (AU)
  • Royal Victorian Eye and Ear Hospital/University of Melbourne; Department of Otolaryngology; 32 Gisborne Street Melbourne Victoria 3002 Australia
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2013-07-02
Volume
2013
Issue
7
Pages
CD003998-CD003998
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1482236737
Cited by
354
References
0
Citations by year
2026: 10 · 2025: 16 · 2024: 16 · 2023: 25 · 2022: 31 · 2021: 18 · 2020: 22 · 2019: 18 · 2018: 20 · 2017: 19 · 2016: 26 · 2015: 21 · 2014: 19 · 2013: 8 · 2012: 22
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Hearing Loss and Rehabilitation
Keywords
idiopathic sudden sensorineural hearing loss, steroids, oral corticosteroids, hearing outcomes, tinnitus, adverse drug reactions, treatment effectiveness, risk of bias, treatment duration, risk of bias assessment, meta-analysis heterogeneity, risk of bias in individual studies, risk of bias assessment tools
MeSH terms
Anti-Inflammatory Agents, Hearing Loss, Sudden, Dexamethasone, Glucocorticoids, Hearing Loss, Sensorineural, Humans, Methylprednisolone, Prednisolone, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review